Back to Journals » OncoTargets and Therapy » Volume 15

LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction]

Authors Duan Y, Zhao M, Jiang M, Li Z, Ni C

Received 3 February 2022

Accepted for publication 3 February 2022

Published 8 February 2022 Volume 2022:15 Pages 145—146

DOI https://doi.org/10.2147/OTT.S361004



Duan Y, Zhao M, Jiang M, Li Z, Ni C. Onco Targets Ther. 2020;13:2701–2710.

At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors have informed the journal that they have concerns with the reliability of the published results. It was also found that several western blot images in Figures 2E, 2G and 2H appear to have been duplicated. The authors were unable to provide a satisfactory explanation for this and were unable to provide any original data relating to their study.

The Editor has agreed with the request to retract the article.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.